col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


82 Results       Page 1

 [1] 
BMJ: ESMO Open
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2023―Jun―21 Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors S.F. Oosting, A.A.M. van der Veldt, R.S.N. Fehrmann, A. Bhattacharya, R.S. van Binnendijk, C.H. GeurtsvanKessel, A.-M.C. Dingemans, E.F. Smit, T.J.N. Hiltermann, G. den Hartog, M. Jalving, T.T. Westphal, F. de Wilt, Sophie M. Ernst, A. Boerma, L. van Zijl, G.F. Rimmelzwaan, P. Kvistborg, C.A.C.M. van Els, N.Y. Rots, D. van Baarle, J.B.A.G. Haanen, E.G.E. de Vries
2 [GO] 2023―Jun―19 Learning Lessons from the COVID-19 pandemic for Real World Evidence research in Oncology - shared perspectives from an international consortia Luís Castelo-Branco, Rebecca Lee, Mariana Brandão, Alessio Cortellini, André Freitas, Marina Garassino, Tatjana Geukens, Petros Grivas, Susan Halabi, Julio Oliveira, David James Pinato, Joana Ribeiro, Solange Peters, George Pentheroudakis, Jeremy L. Warner, Emanuela Romano
3 [GO] 2023―May―31 Tobacco cessation and the role of ESMO and medical oncologists: addressing the specific needs of cancer patients in times of the COVID-19 pandemic R. Krech, S. Peters, H. Kroemer, D. Fu, R. Giuliani, J. Sehouli, A. Ilbawi, V. Prasad, A. Ullrich
4 [GO] 2023―May―15 275P Serological response to COVID-19 vaccine in patients with advanced breast cancer P. Casado Cuesta, F. Pikabea Díaz, E. Galve-Calvo, A. Zumarraga, A. Bilbao Penas, B. López De San Vicente, C. Figaredo Bejarano, I. Bernat Pina, J. Legaspi, J.R. Barceló Galíndez, L. Sande Sardina, M. NuÑo Escolastico, M.T. Abad Villar, M. Lopez, M.T. Pérez Hoyos, M.A. Sala Gonzalez, M. Temiño Francés, P.L. Loaiza Jaramillo, J.L. Díaz de Tuesta del Arco, P. Martinez del Prado
5 [GO] 2023―May―15 271P Impact of COVID-19 vaccination on health-related quality of life in patients with breast cancer M. Forster, R. Würstlein, A. Koenig, A. Stefan, E. Wiegershausen, S. Mahner, N. Harbeck, A. Chelariu-Raicu
6 [GO] 2023―May―04 COVID-19 in cancer patients: Update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases Pierre Martin, Zoi Tsourti, Joana Ribeiro, Luis Castelo-Branco, Evandro de Azambuja, Spyridon Gennatas, Jacobo Rogado, Marina Sekacheva, Snežana Šušnjar, David Viñal, Rebecca Lee, Salah Khallaf, Georgia Dimopoulou, Sylvain Pradervand, Jennifer Whisenant, Toni K. Choueiri, Dirk Arnold, Kevin Harrington, Kevin Punie, Júlio Oliveira, Olivier Michielin, Urania Dafni, Solange Peters, George Pentheroudakis, Emanuela Romano
7 [GO] 2023―Apr―25 Timely course of SARS-CoV-2 infections and vaccinations in patients with hemato-oncological diseases: analysis of a real-life cohort Maximilian J. Mair, Manfred Mitterer, Thomas Buratti, Luzia Berchtold, Dominic Fong, Matthias Preusser
8 [GO] 2023―Apr―03 Vaccination for seasonal flu, pneumococcal infection, and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) Paolo Pedrazzoli, Angioletta Lasagna, Irene Cassaniti, Antonio Piralla, Andrea Squeri, Raffaele Bruno, Paolo Sacchi, Fausto Baldanti, Massimo Di Maio, Giordano Domenico Beretta, Saverio Cinieri, Nicola Silvestris
9 [GO] 2023―Mar―22 67P Detrimental effect of the COVID-19 pandemic on patients with adult extremity bone sarcoma: Reference center experience P. Teterycz, B. Szostakowski, M. Rosinska, H.M. Kosela Paterczyk, P. Rutkowski
10 [GO] 2023―Feb―25 77P The impact of COVID-19 on gynecological cancer diagnoses in Greece O. Fiste, P. Iliopoulou, K. Tzannis, C. Theofanakis, A. Rouvali, C. Markellos, E. Kunadis, E. Potiri, A-M. Papanota, A. Papatheodoridi, A. Andrikopoulou, A. Svarna, M. Kaparelou, K. Koutsoukos, N. Thomakos, D. Haidopoulos, A. Rodolakis, F. Zagouri, M. Dimopoulos, M. Liontos
11 [GO] 2023―Feb―25 13P Cervical cancer screening in a basic health unit in South of Brazil: Impact of the COVID-19 pandemic I.F. Michelon, I. Silveira Pinheiro, M.E. Ayres Obelar, A. Teixeira, C. Amaral, F. Nedel
12 [GO] 2023―Feb―25 79P The situation of gynecological cancer before and after COVID-19 pandemic years in Kosovo B. Profka, D. Berberi
13 [GO] 2023―Jan―10 One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment A.A.M. van der Veldt, S.F. Oosting, R.S.N. Fehrmann, C.H. GeurtsvanKessel, R.S. van Binnendijk, A.-M.C. Dingemans, E.F. Smit, T.J.N. Hiltermann, G. den Hartog, M. Jalving, T.T. Westphal, A. Bhattacharya, F. de Wilt, Sophie M. Ernst, A. Boerma, L. van Zijl, G.F. Rimmelzwaan, P. Kvistborg, C.A.C.M. van Els, N.Y. Rots, D. van Baarle, J.B.A.G. Haanen, E.G.E. de Vries
14 [GO] 2022―Dec―30 PP088 The case fatality rate of COVID-19 infection in non-small cell lung cancer Y.J. Jung, S.H. Park, H.A. Jung, J-M. Sun, S-H. Lee, J.S. Ahn, M-J. Ahn
15 [GO] 2022―Dec―30 OP12 Durability and immunogenicity after two doses of ChAdOx1 nCov-19 among the type of cancer treatment in oncologic patients: A prospective, multicenter observational study P. Wanchaijiraboon, N. Teeyapun, S. Luangdilok, N. Wanlapakorn, P. Sainamthip, N. Pakvisal, T. Namkanisorn, V. Sriuranpong, E. Phaibulvatanapong, R. Veranitinun, P. Inthasuwan, C. Sartsuk, R. Phongwan, P. Angspatt, P. Wongchanapat, Y. Poovorawan, S. Tanasanvimon
16 [GO] 2022―Nov―07 Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future T. Geukens, M. Brandão, A. Laenen, J. Collignon, C. Van Marcke, I. Louviaux, W. Demey, S. Van Wambeke, D. Schrijvers, S. Lecomte, J. Mebis, A. Rutten, C. Fontaine, W. Lybaert, S. Aspeslagh, J.-C. Goeminne, H. Van Den Bulck, E. Seront, L. De Backer, W. De Roock, M. Ignatiadis, H. Prenen, D. Van Beckhoven, M. Heijlen, J. Verheezen, S. Rottey, K. Punie, E. de Azambuja
17 [GO] 2022―Aug―24 Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment Elena Su, Stefanie Fischer, Ruth Demmer-Steingruber, Susanne Nigg, Sabine Güsewell, Werner C. Albrich, Christian Rothermundt, Tobias Silzle, Christian R. Kahlert
18 [GO] 2022―Jul―01 Trials without borders - decentralized trials and ensuring access to novel cancer therapies during a global pandemic Aaron C. Tan, Tira J.Y. Tan, Stephanie P.L. Saw, Justina Y.C. Lam, Yoon Sim Yap, Wan-Teck Lim, David W.M. Tai, Matthew C.H. Ng, Daniel S.W. Tan
19 [GO] 2022―Jun―23 Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera Statement. Giordano D. Beretta, Raffaella Casolino, Domenico C. Corsi, Francesco Perrone, Massimo Di Maio, Saverio Cinieri, Gino Gobber, Marco Bellani, Flavia Petrini, Maria T. Zocchi, Francesca Traclò, Vittorina Zagonel
20 [GO] 2022―May―08 COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO CoCARE) Luis Castelo-Branco, Zoi Tsourti, Spyridon Gennatas, Jacobo Rogado, Marina Sekacheva, David Viñal, Rebecca Lee, Adina Croitoru, Marina Vitorino, Salah Khallaf, Snežana Šušnjar, Widyanti Soewoto, Ana Cardeña, Mohamed Djerouni, Maura Rossi, Teresa Alonso-Gordoa, Corazon Ngelangel, Jennifer G. Whisenant, Toni K. Choueiri, Georgia Dimopoulou, Sylvain Pradervand, Dirk Arnold, Kevin Harrington, Olivier Michielin, Urania Dafni, George Pentheroudakis, Solange Peters, Emanuela Romano
21 [GO] 2022―Apr―14 Cancer diagnosis in Catalonia (Spain) after two years of COVID-19 pandemic: an incomplete recovery Ribes J, Pareja L, Sanz X, Mosteiro S, Escribà JM, Esteban L, Gálvez J, Osca G, Rodenas P, P. Pérez-Sust, Borràs JM
22 [GO] 2022―Apr―01 Erratum to ‘Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario’ L. Cantini, G. Mentrasti, G. Lo Russo, D. Signorelli, G. Pasello, E. Rijavec, M. Russano, L. Antonuzzo, D. Rocco, R. Giusti, V. Adamo, C. Genova, A. Tuzi, A. Morabito, S. Gori, N. La Verde, R. Chiari, A. Cortellini, V. Cognigni, F. Pecci, A. Indini, A. De Toma, E. Zattarin, S. Oresti, E.G. Pizzutilo, S. Frega, E. Erbetta, A. Galletti, F. Citarella, S. Fancelli, E. Caliman, L. Della Gravara, U. Malapelle, M. Filetti, M. Piras, G. Toscano, L. Zullo, M. De Tursi, P. Di Marino, V. D’Emilio, M.S. Cona, A. Guida, A. Caglio, F. Salerno, G.P. Spinelli, C. Bennati, F. Morgillo, A. Russo, C. Dellepiane, I. Vallini, V. Sforza, A. Inno, F. Rastelli, V. Tassi, L. Nicolardi, M.V. Pensieri, R. Emili, E. Roca, A. Migliore, T. Galassi, M.B.L. Rocchi, R. Berardi
23 [GO] 2022―Mar―07 Androgen deprivation therapy and cognitive decline in the NEON-PC prospective study, during the COVID-19 pandemic. Natália Araújo, Adriana Costa, Luisa Lopes-Conceição, Augusto Ferreira, Filipa Carneiro, Jorge Oliveira, Isaac Braga, Samantha Morais, Luís Pacheco-Figueiredo, Luis Ruano, Vítor Tedim Cruz, Susana Pereira, Nuno Lunet
24 [GO] 2022―Mar―02 Postgraduate oncology educational shifts during the COVID-19 pandemic: results of faculty and medical student surveys Antoine Moya-Plana, Lambros Tselikas, Olivier Lambotte, Stephane Temam, Thierry De Baere, Eric Deutsch, Fabrice Barlesi, Pierre Blanchard, Antonin Levy
25 [GO] 2022―Feb―10 Outcomes of patients with cancer infected with SARS-CoV-2: results from the Ion Chiricuță Oncology Institute series Paul Kubelac, Alexandra Preda, Tudor Ciuleanu, Nicolae Todor, Ovidiu Balacescu, Patriciu Achimas-Cadariu, Dana Iancu, Cristina Mocan, Mariana Bandi-Vasilica, Mihaela Lupse, Violeta Tincuta Briciu, Milena Adina Man, Catalin Vlad
26 [GO] 2022―Feb―07 Comparison of S1 antibody titers between BNT162b2 and ChAdOx1 COVID-19 vaccination in cancer patients P.A. van Dam, Y. Debie, L. Teuwen, L. Verbruggen, G. Vanhoutte, B. Peeters, L. Croes, C. Vulsteke, S. Anguille, T. Vandamme, M. Peeters
27 [GO] 2022―Feb―03 Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario Luca Cantini, Giulia Mentrasti, Giuseppe Lo Russo, Diego Signorelli, Giulia Pasello, Erika Rijavec, Marco Russano, Lorenzo Antonuzzo, Danilo Rocco, Raffaele Giusti, Vincenzo Adamo, Carlo Genova, Alessandro Tuzi, Alessandro Morabito, Stefania Gori, Nicla La Verde, Rita Chiari, Alessio Cortellini, Valeria Cognigni, Federica Pecci, Alice Indini, Alessandro De Toma, Emma Zattarin, Sara Oresti, Elio Gregory Pizzutilo, Stefano Frega, Elisa Erbetta, Alessandro Galletti, Fabrizio Citarella, Sara Fancelli, Enrico Caliman, Luigi Della Gravara, Umberto Malapelle, Marco Filetti, Marta Piras, Giuseppe Toscano, Lodovica Zullo, Michele De Tursi, Pietro Di Marino, Vittorio D'Emilio, Maria Silvia Cona, Annalisa Guida, Andrea Caglio, Flavio Salerno, Gianpaolo Spinelli, Chiara Bennati, Floriana Morgillo, Alessandro Russo, Chiara Dellepiane, Ilaria Vallini, Vincenzo Sforza, Alessandro Inno, Francesca Rastelli, Valentina Tassi, Linda Nicolardi, Vittoria Pensieri, Rita Emili, Elisa Roca, Antonella Migliore, Tommaso Galassi, Marco Luigi Bruno Rocchi, Rossana Berardi
28 [GO] 2022―Jan―28 Managing hematological cancer patients during the COVID-19 pandemic: An ESMO-EHA Interdisciplinary Expert Consensus Christian Buske, Martin Dreyling, Alberto Alvarez-Larrán, Jane Apperley, Luca Arcaini, Caroline Besson, Lars Bullinger, Paolo Corradini, Matteo Giovanni Della Porta, Meletios Dimopoulos, Shirley D’Sa, Hans Th. Eich, Robin Foà, Paolo Ghia, Maria Gomes da Silva, John Gribben, Roman Hajek, Claire Harrison, Michael Heuser, Barbara Kiesewetter, Jean Jacques Kiladjian, Nicolaus Kröger, Philippe Moreau, Jakob R. Passweg, Flora Peyvandi, Delphine Rea, Josep-Maria Ribera, Tadeusz Robak, Jesus F. San-Miguel, Valeria Santini, Guillermo Sanz, Pieter Sonneveld, Marie von Lilienfeld-Toal, Clemens Wendtner, George Pentheroudakis, Francesco Passamonti
29 [GO] 2021―Dec―17 The impact of COVID-19 on oncology professionals - one year on: lessons learned from the ESMO Resilience Task Force survey series Kok Haw Jonathan Lim, Krithika Murali, Eleanor Thorne, Kevin Punie, Konstantinos Kamposioras, Christoph Oing, Miriam O’Connor, Elena Élez, Teresa Amaral, Pilar Garrido, Matteo Lambertini, Bharti Devnani, C. Benedikt Westphalen, Gilberto Morgan, John B.A. G. Haanen, Claire Hardy, Susana Banerjee
30 [GO] 2021―Nov―27 Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On study E.M. Ruggeri, F. Nelli, A. Fabbri, A. Onorato, D. Giannarelli, J. R. Giron Berrios, A. Virtuoso, E. Marrucci, M. Mazzotta, M. Schirripa, V. Panichi, G. Pessina, C. Signorelli, M.G. Chilelli, F. Primi, F. Natoni, S. Fazio, M.A. Silvestri
31 [GO] 2021―Nov―23 The impact of COVID-19 on cancer care and oncology clinical research: an experts’ perspective Cristiana Sessa, Jorge Cortes, Pierfranco Conte, Fatima Cardoso, Toni Choueiri, Reinhardt Dummer, Patricia Lorusso, Oliver Ottmann, Bettina Ryll, Tony Mok, Margaret Tempero, Silvia Comis, Cristina Oliva, Solange Peters, Josep Tabernero
32 [GO] 2021―Sep―27 Serologic Response to COVID-19 Infection and/or Vaccine in Cancer Patients on Active Treatment Albert Grinshpun, Yakir Rottenberg, Iddo Z. Ben-Dov, Esther Djian, Dana G. Wolf, Luna Kadouri
33 [GO] 2021―Sep―08 REDUCED HUMORAL IMMUNE RESPONSE AFTER BNT162B2 COVID-19 MRNA VACCINATION IN CANCER PATIENTS UNDER ANTI-NEOPLASTIC TREATMENT M. Peeters, L. Verbruggen, L. Teuwen, G. Vanhoutte, S. Vande Kerckhove, B. Peeters, S. Raats, I. Van der Massen, S. De Keersmaecker, Y. Debie, M. Huizing, P. Pannus, K. Neven, K.K. Ariën, G.A. Martens, M. Van Den Bulcke, E. Roelant, I. Desombere, S. Anguille, M. Goossens, T. Vandamme, P. van Dam
34 [GO] 2021―Jul―26 Identifying and preventing burnout in young oncologists, an overwhelming challenge in the COVID-19 era: a study of the Spanish Society of Medical Oncology (SEOM) P. Jiménez-Labaig, V. Pacheco-Barcia, A. Cebrià, F. Gálvez, B. Obispo, D. Páez, A. Quílez, T. Quintanar, A. Ramchandani, J. Remon, J. Rogado, D.A. Sánchez, M. Sánchez-Cánovas, E. Sanz-García, A. Sesma, N. Tarazona, A. Cotés, E. González, J. Bosch-Barrera, A. Fernández, E. Felip, R. Vera, Á. Rodríguez-Lescure, E. Élez
35 [GO] 2021―Jul―24 Beyond the lessons learned from the Covid19 pandemic: Opportunities to optimize clinical trial implementation in oncology Luis Castelo-Branco, Ahmad Awada, George Pentheroudakis, Jose Luis Perez-Garcia, Joaquin Mateo, Giuseppe Curigliano, Susana Banerjee, Rosa Giuliani, Florian Lordick, Andres Cervantes, Josep Tabernero, Solange Peters
36 [GO] 2021―Jul―09 Impact of COVID-19 on Cancer Service Delivery; a follow up international survey of oncology clinicians Grace Chazan, Fanny Franchini, Marliese Alexander, Susana Banerjee, Linda Mileshkin, Prunella Blinman, Rob Zielinski, Deme Karikios, Nick Pavlakis, Solange Peters, Florian Lordick, David Ball, Gavin Wright, Maarten IJzerman, Benjamin J. Solomon
37 [GO] 2021―Jul―01 The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II K.H.J. Lim, K. Murali, K. Kamposioras, K. Punie, C. Oing, M. O’Connor, E. Thorne, T. Amaral, P. Garrido, M. Lambertini, B. Devnani, C.B. Westphalen, G. Morgan, J.B.A.G. Haanen, C. Hardy, S. Banerjee
38 [GO] 2021―Jun―11 Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis Hanna M. Peacock, Tim Tambuyzer, Freija Verdoodt, Frédéric Calay, Hélène A. Poirel, Harlinde De Schutter, Julie Francart, Nancy Van Damme, Liesbet Van Eycken
39 [GO] 2021―Jun―02 The COVID-19 pandemic could be a setback for gender equality in oncology-and a key moment to push ahead with transformative policies A. Cervantes
40 [GO] 2021―May―27 COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC) F. Bianchi, E. Dama, F. Di Nicolantonio, G. Baldassarre, I. Guerriero, E. Torchiaro, A. Bruno, G. Blandino, P. Allavena, P. Chiarugi, G. Sozzi, M. D’Incalci, N. Normanno
41 [GO] 2021―May―25 Has COVID-19 had a greater impact on female than male oncologists? Results of the ESMO Women for Oncology (W4O) Survey P. Garrido, A.A. Adjei, J. Bajpai, S. Banerjee, A.S. Berghoff, S.P. Choo, E. Felip, A.J.S. Furness, E. Garralda, J. Haanen, A. Letsch, H. Linardou, S. Peters, C. Sessa, J. Tabernero, J. Tsang, J.C-.H. Yang, M.C. Garassino
42 [GO] 2021―Apr―30 Impact of the COVID-19 pandemic on the care of cancer patients in Spain Mariluz Amador, Xavier Matias-Guiu, Gemma Sancho-Pardo, Jorge Contreras Martinez, Julio C. de la Torre-Montero, Angeles Peñuelas Saiz, Pilar Garrido, Ramón García-Sanz, Álvaro Rodríguez-Lescure, Luis Paz-Ares
43 [GO] 2021―Apr―19 Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France J.Y. Blay, S. Boucher, B. Le Vu, C. Cropet, S. Chabaud, D. Perol, E. Barranger, M. Campone, T. Conroy, C. Coutant, R. De Crevoisier, A. Debreuve-Theresette, J.P. Delord, P. Fumoleau, J. Gentil, F. Gomez, O. Guerin, A. Jaffré, E. Lartigau, C. Lemoine, M.A. Mahe, F.X. Mahon, H. Mathieu-Daude, Y. Merrouche, F. Penault-Llorca, X. Pivot, J.C. Soria, G. Thomas, P. Vera, T. Vermeulin, P. Viens, M. Ychou, S. Beaupere
44 [GO] 2021―Apr―08 The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer Gino M. Dettorre, Meera Patel, Alessandra Gennari, George Pentheroudakis, Emanuela Romano, Alessio Cortellini, David J. Pinato
45 [GO] 2021―Apr―07 Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network G. Morgan, M. Tagliamento, M. Lambertini, B. Devnani, B. Westphalen, R. Dienstmann, I. Bozovic-Spasojevic, A. Calles, C. Criscitiello, A. Curioni, A.M. Garcia, A. Lamarca, S. Pilotto, M. Scheffler, M. Strijbos, R. Wong, E. de Azambuja, S. Peters
46 [GO] 2021―Mar―20 COVID-19 Infection in Cancer Patients: What has been the Contribution of Associazione Italiana Oncologia Medica (AIOM) to Oncological Care Since the Beginning of the First Pandemic Wave? Nicola Silvestris, Massimo Di Maio, Antonio Russo, Rita Chiari, Ugo De Giorgi, Lucia Del Mastro, Dario Giuffrida, Nicla La Verde, Francesco Perrone, Marcello Tucci, Giordano Domenico Beretta, Saverio Cinieri
47 [GO] 2021―Feb―06 The impact of COVID-19 on oncology professionals: Results of the ESMO Resilience Task Force survey collaboration Susana Banerjee, Kok Haw Jonathan Lim, Krithika Murali, Konstantinos Kamposioras, Kevin Punie, Christoph Oing, Miriam O’Connor, Eleanor Thorne, Bharti Devnani, Matteo Lambertini, C. Benedikt Westphalen, Pilar Garrido, Teresa Amaral, Gilberto Morgan, John B.A. G. Haanen, Claire Hardy
48 [GO] 2021―Jan―28 Erratum to ‘Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome’ R.J. Lee, O. Wysocki, T. Bhogal, R. Shotton, A. Tivey, A. Angelakas, T. Aung, K. Banfill, M. Baxter, H. Boyce, G. Brearton, E. Copson, E. Dickens, L. Eastlake, F. Gomes, C. Hague, M. Harrison, L. Horsley, P. Huddar, Z. Hudson, S. Khan, U.T. Khan, A. Maynard, H. McKenzie, D. Palmer, T. Robinson, M. Rowe, A. Thomas, J. Tweedy, R. Sheehan, A. Stockdale, J. Weaver, S. Williams, C. Wilson, C. Zhou, C. Dive, T. Cooksley, C. Palmieri, A. Freitas, A.C. Armstrong
49 [GO] 2021―Jan―15 Social distress among Medical Oncologists and other Health Care Professionals during the first wave of COVID-19 pandemic in Italy R. Berardi, M. Torniai, M.S. Cona, F. Cecere, R. Chiari, V. Guarneri, Verde N. La, L. Locati, D. Lorusso, E. Martinelli, D. Giannarelli, M. Garassino
50 [GO] 2021―Jan―05 Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey A.S. Gheorghe, Ş.M. Negru, C. Nițipir, L. Mazilu, M. Marinca, B. Gafton, T.E. Ciuleanu, M. Schenker, R.D. Dragomir, A.D. Gheorghe, P.O. Stovicek, M. Bandi-Vasilica, A.C. Boț, R.I. Mihăilă, D.L. Zob, A.L. Kajanto, D.L. Stănculeanu
51 [GO] 2021―Jan―05 Supportive care in patients with cancer during the COVID-19 pandemic Matti Aapro, Gary H. Lyman, Carsten Bokemeyer, Bernardo L. Rapoport, Nicola Mathieson, Natalia Koptelova, Paul Cornes, Ronald Anderson, Pere Gascón, Nicole M. Kuderer
52 [GO] 2021―Jan―05 Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future P. Hofman, M. Ilié, E. Chamorey, P. Brest, R. Schiappa, V. Nakache, M. Antoine, M. Barberis, H. Begueret, F. Bibeau, C. Bonnetaud, P. Boström, P. Brousset, L. Bubendorf, L. Carvalho, G. Cathomas, A. Cazes, L. Chalabreysse, M.-P. Chenard, M.-C. Copin, J.-F. Côté, D. Damotte, L. de Leval, P. Delongova, V. Thomas de Montpreville, A. de Muret, A. Dema, W. Dietmaier, M. Evert, A. Fabre, F. Forest, A. Foulet, S. Garcia, M. Garcia-Martos, L. Gibault, G. Gorkiewicz, D. Jonigk, J. Gosney, A. Hofman, I. Kern, K. Kerr, M. Kossai, M. Kriegsmann, S. Lassalle, E. Long-Mira, A. Lupo, A. Mamilos, R. Matěj, J. Meilleroux, C. Ortiz-Villalón, L. Panico, A. Panizo, M. Papotti, P. Pauwels, G. Pelosi, F. Penault-Llorca, O. Pop, N. Poté, S.R.Y. Cajal, J.-C. Sabourin, I. Salmon, M. Sajin, S. Savic-Prince, H.-U. Schildhaus, P. Schirmacher, I. Serre, E. Shaw, D. Sizaret, A. Stenzinger, J. Stojsic, E. Thunnissen, W. Timens, G. Troncone, C. Werlein, H. Wolff, J.-P. Berthet, J. Benzaquen, C.-H. Marquette, V. Hofman, F. Calabrese
53 [GO] 2021―Jan―05 Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome R.J. Lee, O. Wysocki, T. Bhogal, R. Shotton, A. Tivey, A. Angelakas, T. Aung, K. Banfill, M. Baxter, H. Boyce, G. Brearton, E. Copson, E. Dickens, L. Eastlake, F. Gomes, C. Hague, M. Harrison, L. Horsley, P. Huddar, Z. Hudson, S. Khan, U.T. Khan, A. Maynard, H. McKenzie, D. Palmer, T. Robinson, M. Rowe, A. Thomas, J. Tweedy, R. Sheehan, A. Stockdale, J. Weaver, S. Williams, C. Wilson, C. Zhou, C. Dive, T. Cooksley, C. Palmieri, A. Freitas, A.C. Armstrong
54 [GO] 2020―Dec―01 Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians Grace Chazan, Fanny Franchini, Marliese Alexander, Susana Banerjee, Linda Mileshkin, Prunella Blinman, Rob Zielinski, Deme Karikios, Nick Pavlakis, Solange Peters, Florian Lordick, David Ball, Gavin Wright, Maarten IJzerman, Benjamin Solomon
55 [GO] 2020―Nov―06 COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study Federico Nichetti, Marta Bini, Margherita Ambrosini, Arianna Ottini, Alessandro Rametta, Rita Leporati, Daniela Polastri, Chiara Pircher, Katia Dotti, Laura Ferrari, Filippo de Braud
56 [GO] 2020―Oct―23 Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy Dawid Sigorski, Paweł Sobczuk, Małgorzata Osmola, Kamil Kuć, Anna Walerzak, Michal Wilk, Tomasz Ciszewski, Sylwia Kopeć, Karolina Hryń, Piotr Rutkowski, Rafał Stec, Cezary Szczylik, Lubomir Bodnar
57 [GO] 2020―Oct―22 Correction: Oncological care organisation during COVID-19 outbreak
58 [GO] 2020―Oct―13 Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change? Domenica Lorusso, Isabelle Ray-Coquard, Ana Oaknin, Susana Banerjee
59 [GO] 2020―Sep―25 Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis Evandro de Azambuja, Mariana Brandão, Hans Wildiers, Annouschka Laenen, Sandrine Aspeslagh, Christel Fontaine, Joelle Collignon, Willem Lybaert, Jolanda Verheezen, Annemie Rutten, Peter Vuylsteke, Jean-Charles Goeminne, Wim Demey, Dominique Van Beckhoven, Jessika Deblonde, Sylvie Rottey, Tatjana Geukens, Kevin Punie
60 [GO] 2020―Sep―21 Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era Grazia Arpino, Carmine De Angelis, Pietro De Placido, Erica Pietroluongo, Luigi Formisano, Roberto Bianco, Giovanni Fiore, Emma Montella, Valeria Forestieri, Rossella Lauria, Cinzia Cardalesi, Emilia Anna Vozzella, Anna Iervolino, Mario Giuliano, Sabino De Placido
61 [GO] 2020―Sep―02 SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic Thorsten Fuereder, Anna Sophie Berghoff, Gerwin Heller, Helmuth Haslacher, Thomas Perkmann, Robert Strassl, Julia Maria Berger, Hannah Christina Puhr, Judith Kreminger, Florian Moik, Lorenz Schubert, Angelika Martina Starzer, Ariane Steindl, Stefan Winkler, Matthias Preusser, Selma Tobudic
62 [GO] 2020―Aug―27 Oncological care organisation during COVID-19 outbreak Concetta Elisa Onesti, Hope S Rugo, Daniele Generali, Marc Peeters, Khalil Zaman, Hans Wildiers, Nadia Harbeck, Miguel Martin, Massimo Cristofanilli, Javier Cortes, Vivianne Tjan-Heijnen, Sara A Hurvitz, Guy Berchem, Marco Tagliamento, Mario Campone, Rupert Bartsch, Sabino De Placido, Fabio Puglisi, Sylvie Rottey, Volkmar Müller, Thomas Ruhstaller, Jean-Pascal Machiels, PierFranco Conte, Ahmad Awada, Guy Jerusalem
63 [GO] 2020―Jul―27 ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies Ilaria Colombo, Eleonora Zaccarelli, Maria Del Grande, Federica Tomao, Francesco Multinu, Ilaria Betella, Jonathan A Ledermann, Antonio Gonzalez-Martin, Cristiana Sessa, Nicoletta Colombo
64 [GO] 2020―Jul―15 Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma Stefanie Aeppli, Eric Innocents Eboulet, Tim Eisen, Bernard Escudier, Stefanie Fischer, James Larkin, Viktor Gruenwald, David McDermott, Jan Oldenburg, Aurelius Omlin, Camillo Porta, Brian Rini, Manuela Schmidinger, Cora Sternberg, Christian Rothermundt
65 [GO] 2020―Jul―13 Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy? Alberto Zambelli, Carlo Alberto Tondini
66 [GO] 2020―Jun―24 ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer Antonio Passaro, Alfredo Addeo, Christophe Von Garnier, Fiona Blackhall, David Planchard, Enriqueta Felip, Rafal Dziadziuszko, Filippo de Marinis, Martin Reck, Hasna Bouchaab, Solange Peters
67 [GO] 2020―Jun―22 Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform Marc Peeters, Peter van Dam, Marika Anna Rasschaert, Christof Vulsteke, Sven De Keersmaecker, Lieselot Croes, Ilse Van Brussel, Jo Ravelingien, Annelies Janssens, Hans Prenen
68 [GO] 2020―Jun―22 Impact of the COVID-19 outbreak on cancer patient flow and management: experience from a large university hospital in Spain Luis Manso, Guillermo De Velasco, Luis Paz-Ares
69 [GO] 2020―Jun―11 Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy Dominic Fong, Simon Rauch, Christian Petter, Eva Haspinger, Monika Alber, Manfred Mitterer
70 [GO] 2020―May―26 ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer Loredana Vecchione, Sebastian Stintzing, George Pentheroudakis, Jean-Yves Douillard, Florian Lordick
71 [GO] 2020―May―26 Cancer datasets and the SARS-CoV-2 pandemic: establishing principles for collaboration Carlo Palmieri, Daniel Palmer, Peter JM Openshaw, J Kenneth Baille, Malcolm G Semple, Lance Turtle
72 [GO] 2020―May―21 ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer Evandro de Azambuja, Dario Trapani, Sibylle Loibl, Suzette Delaloge, Elzbieta Senkus, Carmen Criscitiello, Philip Poortman, Michael Gnant, Serena Di Cosimo, Javier Cortes, Fatima Cardoso, Shani Paluch-Shimon, Giuseppe Curigliano
73 [GO] 2020―May―18 ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer Silvia Catanese, George Pentheroudakis, Jean-Yves Douillard, Florian Lordick
74 [GO] 2020―May―14 How we treat patients with brain tumour during the COVID-19 pandemic Michael Weller, Matthias Preusser
75 [GO] 2020―May―14 How we treat patients with lung cancer during the SARS-CoV-2 pandemic Mariano Provencio, Alberto Ruano-Raviña
76 [GO] 2020―May―12 Brief letter of a doctor to his psychologist in the COVID-19 outbreak era Daniele Santini, Giuseppe Tonini
77 [GO] 2020―May―07 Call for ensuring cancer care continuity during COVID-19 pandemic Marco Tagliamento, Matteo Lambertini, Carlo Genova, Emanuela Barisione, Andrea De Maria, Marco Grosso, Francesca Poggio, Stefano Vagge, Francesco Boccardo, Paolo Pronzato, Lucia Del Mastro
78 [GO] 2020―May―04 Editorial debate: Challenges an oncologist has to face during the SARS-CoV-2 pandemic within a universal healthcare system Camillo Porta
79 [GO] 2020―Apr―30 Indications regarding the management of interventional clinical trials with drugs during the current COVID-19 emergency in Italy Carmine Pinto, Celeste Cagnazzo
80 [GO] 2020―Apr―15 Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists Icro Meattini, Pierfrancesco Franco, Liliana Belgioia, Luca Boldrini, Angela Botticella, Maria Carmen De Santis, Giulia Marvaso, Giampaolo Montesi, Silvana Parisi, Luca Triggiani, Matteo Lambertini, Lorenzo Livi
81 [GO] 2020―Apr―03 How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere Giuseppe Banna, Alessandra Curioni-Fontecedro, Alex Friedlaender, Alfredo Addeo
82 [GO] 2020―Mar―30 Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective Matteo Lambertini, Angela Toss, Antonio Passaro, Carmen Criscitiello, Chiara Cremolini, Claudia Cardone, Fotios Loupakis, Giuseppe Viscardi, Icro Meattini, Maria Vittoria Dieci, Roberto Ferrara, Raffaele Giusti, Massimo Di Maio
 [1] 

82 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec